Elevara

Series-A
elevara.com Biotech & Healthcare London, United Kingdom Founded 2026 11–50 employees
Total Funding $70M
Latest Round $70M Series-A
Last Announced Oct 24, 2025
Investors 4 Backers
Decision Makers 1 Available

About Elevara

Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters London, United Kingdom
Year Founded 2026
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website elevara.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Milestone

    Company founded

    London, United Kingdom

  2. Capital Raise

    Raised $70,000,000 · Series-A

    Backed by Forbion Capital Partners

Investors & Backers

4
Forbion Capital Partners
Lead
Monograph Capital
Sofinnova Partners
Weatherden

Funding History

1 Round
Series-A equity · Oct 24, 2025

Round backers: Forbion Capital Partners

$70,000,000 news.google.com

Founders & Leadership

4

Emma Tinsley

founder and CEO

Work email & phone locked Unlock →

Kirsty Wydenbach

Head of Regulatory

Work email & phone locked Unlock →

Mai-Britt Zocca

CEO

Work email & phone locked Unlock →

Tim Funnell

Chief Operating Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts